The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to Serum Institute of India (SII) to manufacture…
Browsing: SII
Serum Institute of India’s (SII) Cervavac, a quadrivalent human papillomavirus (qHPV) vaccine is likely to be the first indigenous qHPV…
Serum Institute of India (SII) CEO Adar Poonawalla on Monday said he is appealing to multilateral organisations and world leaders…
The Serum Institute of India has urged the Centre to use the available 10 crore doses of Covishield offered free…
A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals,…
Serum Institute of India has cut the price of the Covishield precaution dose at private hospitals by more than half…
According to a statement, the collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable…
India’s drug regulator had granted restricted emergency use authorisation to Covovax for 12 to 17 years subject to certain conditions…
Unvaccinated people account for 92 per cent of COVID-19 deaths since January this year, the government said. Covid-19 is on…
Serum Institute of India (SII), on October 25, had applied to the Drugs Controller General of India (DCGI) seeking regular…